Caribou Biosciences, Inc. (CRBU)
0.4232
-0.02
(-4.90%)
USD |
NASDAQ |
Oct 30, 16:00
0.43
+0.01
(+1.61%)
After-Hours: 20:00
Caribou Biosciences Price to Book Value : 0.4573 for Oct. 30, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 30, 2026 | 0.4573 |
| October 29, 2026 | 0.4808 |
| October 28, 2026 | 0.5288 |
| October 27, 2026 | 0.4978 |
| October 26, 2026 | 0.5318 |
| October 23, 2026 | 0.5757 |
| October 22, 2026 | 0.6051 |
| October 21, 2026 | 0.5882 |
| October 20, 2026 | 0.5608 |
| October 19, 2026 | 0.5013 |
| October 16, 2026 | 0.5077 |
| October 15, 2026 | 0.5021 |
| October 14, 2026 | 0.4971 |
| October 13, 2026 | 0.5078 |
| October 12, 2026 | 0.5369 |
| October 09, 2026 | 0.4972 |
| October 08, 2026 | 0.5199 |
| October 07, 2026 | 0.6671 |
| October 06, 2026 | 1.226 |
| October 05, 2026 | 1.286 |
| October 02, 2026 | 1.318 |
| October 01, 2026 | 1.318 |
| September 30, 2026 | 1.372 |
| September 29, 2026 | 1.340 |
| September 28, 2026 | 1.329 |
| Date | Value |
|---|---|
| September 25, 2026 | 1.340 |
| September 24, 2026 | 1.351 |
| September 23, 2026 | 1.394 |
| September 22, 2026 | 1.448 |
| September 21, 2026 | 1.405 |
| September 18, 2026 | 1.405 |
| September 17, 2026 | 1.415 |
| September 16, 2026 | 1.351 |
| September 15, 2026 | 1.372 |
| September 14, 2026 | 1.394 |
| September 11, 2026 | 1.372 |
| September 10, 2026 | 1.480 |
| September 09, 2026 | 1.556 |
| September 08, 2026 | 1.664 |
| September 04, 2026 | 1.696 |
| September 03, 2026 | 1.696 |
| September 02, 2026 | 1.729 |
| September 01, 2026 | 1.675 |
| August 31, 2026 | 1.664 |
| August 28, 2026 | 1.750 |
| August 27, 2026 | 1.794 |
| August 26, 2026 | 1.783 |
| August 25, 2026 | 1.902 |
| August 24, 2026 | 1.772 |
| August 21, 2026 | 1.794 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Anavex Life Sciences Corp. | 0.981 |
| Intellia Therapeutics, Inc. | 2.399 |
| Vir Biotechnology, Inc. | 1.946 |
| Vaxcyte, Inc. | 3.256 |
| Foghorn Therapeutics, Inc. | -- |
Price to Book Value Related Metrics
| PS Ratio | 4.056 |
| Price | 0.4232 |
| Earnings Yield | -254.6% |
| Market Cap | 44.86M |